{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:43:05Z","timestamp":1793922185889,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["267788"],"award-info":[{"award-number":["267788"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["2737991"],"award-info":[{"award-number":["2737991"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["250275"],"award-info":[{"award-number":["250275"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FinPharma Doctoral Programme"},{"DOI":"10.13039\/501100003125","name":"Suomen Kulttuurirahasto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004756","name":"Emil Aaltosen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00221-017-4962-z","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T13:52:12Z","timestamp":1493041932000},"page":"2189-2202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson\u2019s disease in young and adult mouse"],"prefix":"10.1007","volume":"235","author":[{"given":"Mari H.","family":"Savolainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Airavaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-6687","authenticated-orcid":false,"given":"Timo T.","family":"My\u00f6h\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"4962_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/syn.20245","volume":"59","author":"M Airavaara","year":"2006","unstructured":"Airavaara M, Mijatovic J, Vihavainen T et al (2006) In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered. Synapse 59:321\u2013329","journal-title":"Synapse"},{"key":"4962_CR2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnbeh.2015.00068","volume":"9","author":"E Bentea","year":"2015","unstructured":"Bentea E, Van der Perren A, Van Liefferinge J et al (2015) Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated alpha-synuclein. Front Behav Neurosci 9:68","journal-title":"Front Behav Neurosci"},{"key":"4962_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114:231\u2013241","journal-title":"Acta Neuropathol"},{"key":"4962_CR4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R et al (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295","journal-title":"Science"},{"key":"4962_CR5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","volume":"45","author":"M Decressac","year":"2012","unstructured":"Decressac M, Mattsson B, Lundblad M et al (2012) Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol Dis 45:939\u2013953","journal-title":"Neurobiol Dis"},{"key":"4962_CR6","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","volume":"31","author":"D Ebrahimi-Fakhari","year":"2011","unstructured":"Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z et al (2011) Distinct roles in vivo for the ubiquitin\u2013proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. J Neurosci 31:14508\u201314520","journal-title":"J Neurosci"},{"key":"4962_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/auto.8.2.18938","volume":"8","author":"D Ebrahimi-Fakhari","year":"2012","unstructured":"Ebrahimi-Fakhari D, McLean PJ, Unni VK (2012) Alpha-synuclein\u2019s degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease. Autophagy 8:281\u2013283","journal-title":"Autophagy"},{"key":"4962_CR8","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00429-015-1045-4","volume":"221","author":"JL Elson","year":"2016","unstructured":"Elson JL, Yates A, Pienaar IS (2016) Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats. Brain Struct Funct 221:2319\u20132341","journal-title":"Brain Struct Funct"},{"key":"4962_CR9","doi-asserted-by":"crossref","first-page":"E912","DOI":"10.1073\/pnas.1512876113","volume":"113","author":"M-B Fares","year":"2016","unstructured":"Fares M-B, Maco B, Oueslati A et al (2016) Induction of de novo \u03b1-synuclein fibrillization in a neuronal model for Parkinson\u2019s disease. Proc Natl Acad Sci 113:E912\u2013E921","journal-title":"Proc Natl Acad Sci"},{"key":"4962_CR10","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1074\/jbc.273.15.8545","volume":"273","author":"G Fenteany","year":"1998","unstructured":"Fenteany G, Schreiber SL (1998) Lactacystin, proteasome function, and cell fate. J Biol Chem 273:8545\u20138548","journal-title":"J Biol Chem"},{"key":"4962_CR11","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1523\/JNEUROSCI.23-26-08955.2003","volume":"23","author":"F Fornai","year":"2003","unstructured":"Fornai F, Lenzi P, Gesi M et al (2003) Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. J Neurosci 23:8955\u20138966","journal-title":"J Neurosci"},{"key":"4962_CR12","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","volume":"102","author":"F Fornai","year":"2005","unstructured":"Fornai F, Schl\u00fcter OM, Lenzi P et al (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin\u2013proteasome system and alpha-synuclein. Proc Natl Acad Sci USA 102:3413\u20133418","journal-title":"Proc Natl Acad Sci USA"},{"key":"4962_CR13","volume-title":"The mouse brain in stereotaxic coordinates","author":"K Franklin","year":"1997","unstructured":"Franklin K, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego"},{"key":"4962_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0079-6123(06)60017-4","volume":"160","author":"A Galvan","year":"2007","unstructured":"Galvan A, Wichmann T (2007) GABAergic circuits in the basal ganglia and movement disorders. Prog Brain Res 160:287\u2013312","journal-title":"Prog Brain Res"},{"key":"4962_CR15","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","volume":"28","author":"HM Gao","year":"2008","unstructured":"Gao HM, Kotzbauer PT, Uryu K et al (2008) Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 28:7687\u20137698","journal-title":"J Neurosci"},{"key":"4962_CR16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/01.WNL.0000078192.95645.E6","volume":"61","author":"A Gerhard","year":"2003","unstructured":"Gerhard A, Banati RB, Goerres GB et al (2003) [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61:686\u2013689","journal-title":"Neurology"},{"key":"4962_CR17","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/glia.20870","volume":"57","author":"O Goldbaum","year":"2009","unstructured":"Goldbaum O, Riedel M, Stahnke T, Richter-Landsberg C (2009) The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition. Glia 57:1566\u20131577","journal-title":"Glia"},{"key":"4962_CR18","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1111\/bph.13208","volume":"172","author":"IF Harrison","year":"2015","unstructured":"Harrison IF, Crum WR, Vernon AC, Dexter DT (2015) Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson\u2019s is associated with histone acetylation and up-regulation of neurotrophic factors. Br J Pharmacol 172:4200\u20134215","journal-title":"Br J Pharmacol"},{"key":"4962_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2015.12.052","volume":"614","author":"IF Harrison","year":"2016","unstructured":"Harrison IF, Anis HK, Dexter DT (2016) Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate. Neurosci Lett 614:16\u201323","journal-title":"Neurosci Lett"},{"key":"4962_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S Iannaccone","year":"2013","unstructured":"Iannaccone S, Cerami C, Alessio M et al (2013) In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord 19:47\u201352","journal-title":"Parkinsonism Relat Disord"},{"key":"4962_CR21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M et al (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains. Acta Neuropathol 106:518\u2013526","journal-title":"Acta Neuropathol"},{"key":"4962_CR22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molbrainres.2004.10.003","volume":"134","author":"J Jin","year":"2005","unstructured":"Jin J, Meredith GE, Chen L et al (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson\u2019s disease. Brain Res Mol Brain Res 134:119\u2013138","journal-title":"Brain Res Mol Brain Res"},{"key":"4962_CR23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","volume":"159","author":"PJ Kahle","year":"2001","unstructured":"Kahle PJ, Neumann M, Ozmen L et al (2001) Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol 159:2215\u20132225","journal-title":"Am J Pathol"},{"key":"4962_CR24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"4962_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbr.2013.12.019","volume":"261","author":"J Konieczny","year":"2014","unstructured":"Konieczny J, Czarnecka A, Lenda T et al (2014a) Chronic l-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra. Behav Brain Res 261:79\u201388","journal-title":"Behav Brain Res"},{"key":"4962_CR26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12640-014-9477-9","volume":"26","author":"J Konieczny","year":"2014","unstructured":"Konieczny J, Jantas D, Lenda T et al (2014b) Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson\u2019s disease. Neurotox Res 26:255\u2013273","journal-title":"Neurotox Res"},{"key":"4962_CR27","doi-asserted-by":"crossref","first-page":"e1005710","DOI":"10.1371\/journal.pgen.1005710","volume":"11","author":"A Kumar","year":"2015","unstructured":"Kumar A, Kopra J, Varendi K et al (2015) GDNF overexpression from the native locus reveals its role in the nigrostriatal dopaminergic system function. PLoS Genet 11:e1005710","journal-title":"PLoS Genet"},{"key":"4962_CR28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2008.02.030","volume":"1205","author":"SJ Kwon","year":"2008","unstructured":"Kwon SJ, Ahn TB, Yoon MY, Jeon BS (2008) BV-2 stimulation by lactacystin results in a strong inflammatory reaction and apoptotic neuronal death in SH-SY5Y cells. Brain Res 1205:116\u2013121","journal-title":"Brain Res"},{"key":"4962_CR29","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Suk JE, Patrick C et al (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272","journal-title":"J Biol Chem"},{"key":"4962_CR30","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s11064-010-0214-3","volume":"35","author":"C Li","year":"2010","unstructured":"Li C, Guo Y, Xie W et al (2010) Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson\u2019s disease. Neurochem Res 35:1546\u20131556","journal-title":"Neurochem Res"},{"key":"4962_CR31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuint.2011.03.013","volume":"58","author":"E Lorenc-Koci","year":"2011","unstructured":"Lorenc-Koci E, Lenda T, Antkiewicz-Michaluk L et al (2011) Different effects of intranigral and intrastriatal administration of the proteasome inhibitor lactacystin on typical neurochemical and histological markers of Parkinson\u2019s disease in rats. Neurochem Int 58:839\u2013849","journal-title":"Neurochem Int"},{"key":"4962_CR32","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","volume":"285","author":"H Lou","year":"2010","unstructured":"Lou H, Montoya SE, Alerte TN et al (2010) Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J Biol Chem 285:17648\u201317661","journal-title":"J Biol Chem"},{"key":"4962_CR33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","volume":"8","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y, Vila M, Lincoln S et al (2001) Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis 8:535\u2013539","journal-title":"Neurobiol Dis"},{"key":"4962_CR34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"4962_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson\u2019s disease. Neurosci Lett 297:191\u2013194","journal-title":"Neurosci Lett"},{"key":"4962_CR36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00001756-200208070-00018","volume":"13","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Bjorklund LM, Belizaire R et al (2002) Proteasome inhibition causes nigral degeneration with inclusion bodies in rats. NeuroReport 13:1437\u20131441","journal-title":"NeuroReport"},{"key":"4962_CR37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O et al (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179:38\u201346","journal-title":"Exp Neurol"},{"key":"4962_CR38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","volume":"956","author":"GE Meredith","year":"2002","unstructured":"Meredith GE, Totterdell S, Petroske E et al (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease. Brain Res 956:156\u2013165","journal-title":"Brain Res"},{"key":"4962_CR39","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1096\/fj.08-127696","volume":"23","author":"J Middeldorp","year":"2009","unstructured":"Middeldorp J, Kamphuis W, Sluijs JA et al (2009) Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. FASEB J 23:2710\u20132726","journal-title":"FASEB J"},{"key":"4962_CR40","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1523\/JNEUROSCI.5647-06.2007","volume":"27","author":"J Mijatovic","year":"2007","unstructured":"Mijatovic J, Airavaara M, Planken A et al (2007) Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra. J Neurosci 27:4799\u20134809","journal-title":"J Neurosci"},{"key":"4962_CR41","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.neurobiolaging.2009.08.009","volume":"32","author":"J Mijatovic","year":"2011","unstructured":"Mijatovic J, Piltonen M, Alberton P et al (2011) Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals. Neurobiol Aging 32:1486\u20131494","journal-title":"Neurobiol Aging"},{"key":"4962_CR42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2012.01846.x","volume":"166","author":"TT My\u00f6h\u00e4nen","year":"2012","unstructured":"My\u00f6h\u00e4nen TT, Hannula MJ, Van Elzen R et al (2012) A prolyl oligopeptidase inhibitor, KYP-2047, reduces alpha-synuclein protein levels and aggregates in cellular and animal models of Parkinson\u2019s disease. Br J Pharmacol 166:1097\u20131113","journal-title":"Br J Pharmacol"},{"key":"4962_CR43","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","volume":"131","author":"T Pan","year":"2008","unstructured":"Pan T, Kondo S, Le W, Jankovic J (2008a) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease. Brain 131:1969\u20131978","journal-title":"Brain"},{"key":"4962_CR44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2008.06.003","volume":"32","author":"T Pan","year":"2008","unstructured":"Pan T, Kondo S, Zhu W et al (2008b) Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 32:16\u201325","journal-title":"Neurobiol Dis"},{"key":"4962_CR45","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","volume":"22","author":"RG Perez","year":"2002","unstructured":"Perez RG, Waymire JC, Lin E et al (2002) A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci 22:3090\u20133099","journal-title":"J Neurosci"},{"key":"4962_CR46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","volume":"220","author":"IS Pienaar","year":"2015","unstructured":"Pienaar IS, Harrison IF, Elson JL et al (2015) An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson\u2019s disease. Brain Struct Funct 220:479\u2013500","journal-title":"Brain Struct Funct"},{"key":"4962_CR47","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1523\/JNEUROSCI.22-12-05137.2002","volume":"22","author":"P Salin","year":"2002","unstructured":"Salin P, Manrique C, Forni C, Kerkerian-Le Goff L (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J Neurosci 22:5137\u20135148","journal-title":"J Neurosci"},{"key":"4962_CR48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert T, Fleming SM, Leasure JL et al (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777\u2013787","journal-title":"Neuropharmacology"},{"key":"4962_CR49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/aps.2012.203","volume":"34","author":"YF Shen","year":"2013","unstructured":"Shen YF, Tang Y, Zhang XJ et al (2013) Adaptive changes in autophagy after UPS impairment in Parkinson\u2019s disease. Acta Pharmacol Sin 34:667\u2013673","journal-title":"Acta Pharmacol Sin"},{"key":"4962_CR50","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","volume":"278","author":"H Snyder","year":"2003","unstructured":"Snyder H, Mensah K, Theisler C et al (2003) Aggregated and monomeric alpha-synuclein bind to the S6\u2032 proteasomal protein and inhibit proteasomal function. J Biol Chem 278:11753\u201311759","journal-title":"J Biol Chem"},{"key":"4962_CR51","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R et al (1998) alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469\u20136473","journal-title":"Proc Natl Acad Sci USA"},{"key":"4962_CR52","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","volume":"100","author":"JL St Martin","year":"2007","unstructured":"St Martin JL, Klucken J, Outeiro TF et al (2007) Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem 100:1449\u20131457","journal-title":"J Neurochem"},{"key":"4962_CR53","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","volume":"22","author":"N Stefanova","year":"2007","unstructured":"Stefanova N, Reindl M, Neumann M et al (2007) Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord 22:2196\u20132203","journal-title":"Mov Disord"},{"key":"4962_CR54","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B et al (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278:44405\u201344411","journal-title":"J Biol Chem"},{"key":"4962_CR55","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","volume":"26","author":"GK Tofaris","year":"2006","unstructured":"Tofaris GK, Garcia Reitbock P, Humby T et al (2006) Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein (1\u2013120): implications for Lewy body disorders. J Neurosci 26:3942\u20133950","journal-title":"J Neurosci"},{"key":"4962_CR56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0079-6123(10)84005-1","volume":"184","author":"A Ulusoy","year":"2010","unstructured":"Ulusoy A, Decressac M, Kirik D, Bj\u00f6rklund A (2010) Viral vector-mediated overexpression of \u03b1-synuclein as a progressive model of Parkinson\u2019s disease. Prog Brain Res 184:89\u2013111","journal-title":"Prog Brain Res"},{"key":"4962_CR57","doi-asserted-by":"crossref","first-page":"e17269","DOI":"10.1371\/journal.pone.0017269","volume":"6","author":"AC Vernon","year":"2011","unstructured":"Vernon AC, Crum WR, Johansson SM, Modo M (2011) Evolution of extra-nigral damage predicts behavioural deficits in a rat proteasome inhibitor model of Parkinson\u2019s disease. PLoS One 6:e17269","journal-title":"PLoS One"},{"key":"4962_CR58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Hayashi S, Yoshimoto M et al (2000) NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol 99:14\u201320","journal-title":"Acta Neuropathol"},{"key":"4962_CR59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.brainres.2010.02.008","volume":"1324","author":"Y Wang","year":"2010","unstructured":"Wang Y, Zhang QJ, Liu J et al (2010) Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson\u2019s disease. Brain Res 1324:54\u201363","journal-title":"Brain Res"},{"key":"4962_CR60","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK et al (2011) In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA 108:4194\u20134199","journal-title":"Proc Natl Acad Sci USA"},{"key":"4962_CR61","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1074\/jbc.274.28.19509","volume":"274","author":"SJ Wood","year":"1999","unstructured":"Wood SJ (1999) alpha-synuclein fibrillogenesis is nucleation-dependent. J Biol Chem 274:19509\u201319512","journal-title":"J Biol Chem"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00221-017-4962-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-017-4962-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00221-017-4962-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T18:56:05Z","timestamp":1719168965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00221-017-4962-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4962"],"URL":"https:\/\/doi.org\/10.1007\/s00221-017-4962-z","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"assertion":[{"value":"21 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed, and the use of experimental animals was approved by the Finnish National Board of Animal Experiments (ESAVI\/198\/04.10.07\/2014).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}